CA IX plasma concentration and CA activity were evaluated on plasma samples obtained by 24 patients (eight with ccRCC, eight with benign renal tumour, and eight healthy volunteers as described in Material and methods). The gene discussed is CA9; the disease is nonpapillary renal cell carcinoma.